CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale See Remarks sold 1,311 shares at $13.33 ($17,476)
- 4 Open-market sale See Remarks sold 2,209 shares at an average $13.18 ($29,116)
- 4 Open-market sale Chief Operating Officer sold 1,559 shares at $13.33 ($20,781)
- 4 Open-market sale Chief Medical Officer sold 7,441 shares at $13.33 ($99,189)
- 4 Open-market sale See Remarks sold 7,318 shares at $13.33 ($97,549)
- 4 Open-market sale Chief Scientific Officer sold 1,416 shares at $13.33 ($18,875)
- 4 Open-market sale See Remarks sold 10,000 shares at $14.03 ($140,300)
- 4 Open-market sale See Remarks sold 30,150 shares at $11.57 ($348,836)
- 4 Open-market buy Director bought 934,581 shares at $10.70 ($10,000,017)
- 4 Open-market buy 10% owner bought 934,581 shares at $10.70 ($10,000,017)
- 4 Open-market sale See Remarks sold 312 shares at $10.87 ($3,391)
- 4 Open-market sale See Remarks sold 472 shares at $10.87 ($5,131)
- 4 Open-market sale Chief Operating Officer sold 751 shares at $10.87 ($8,163)
- 4 Open-market sale Chief Medical Officer sold 628 shares at $10.87 ($6,826)
- 4 Open-market sale See Remarks sold 3,322 shares at $10.87 ($36,110)
- 4 Open-market sale Chief Scientific Officer sold 680 shares at $10.87 ($7,392)
Page 13 of 19 · 365 filings